SCHEMBL837043

SCHEMBL837043

CC(=O)COc1c(C)cc(CN)cc1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
ALDH1A1 P00352 3/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.35
HPGD P15428 3/20 0.35
HSD17B10 Q99714 3/20 0.35
PTPRB P23467 1/20 0.35
KDM4E B2RXH2 3/20 0.35
MAPT P10636 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 1/20 0.34
CASP1 P29466 1/20 0.34
MAPK1 P28482 1/20 0.34
LOXL2 Q9Y4K0 2/20 0.33
SCN4A P35499 2/20 0.33
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL836674 0.81 KMT2A (0.41) KMT2AMEN1ALDH1A1POLBSMN1; SMN2
SCHEMBL14997055 0.81 MAPT (0.47) KMT2AMEN1ALDH1A1POLBSMN1; SMN2
SCHEMBL3190087 0.78 MEN1 (0.59) KMT2AMEN1ALDH1A1POLBSMN1; SMN2
SCHEMBL836544 0.75 MAPT (0.40) KMT2AMEN1ALDH1A1POLBHPGD
SCHEMBL12936082 0.75 HTR2A (0.43) ALDH1A1HPGDHSD17B10KDM4EMAPT
SCHEMBL4687492 0.74 HTR1A (0.42) KMT2AMEN1ALDH1A1HSD17B10KDM4E
SCHEMBL10097969 0.74 MEN1 (0.38) KMT2AMEN1ALDH1A1POLBHPGD
SCHEMBL836680 0.74 ALDH1A1 (0.40) KMT2AMEN1ALDH1A1POLBSMN1; SMN2
SCHEMBL836542 0.73 KMT2A (0.56) KMT2AMEN1ALDH1A1POLBSMN1; SMN2
SCHEMBL4685426 0.73 S1PR1 (0.39) KMT2AMEN1ALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143421-B2 Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2012-03-27 US disclosed
US-8143421-B2 Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2012-03-27 US disclosed
US-20090203743-A1 SMALL MOLECULE ENTRY INHIBITORS SURLERAUX DOMINIQUE LOUIS 2009-08-13 US disclosed
US-20090203743-A1 SMALL MOLECULE ENTRY INHIBITORS SURLERAUX DOMINIQUE LOUIS 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203743-A1 SMALL MOLECULE ENTRY INHIBITORS NR0B1, LTC4S, LTB4R KMT2A 3153/4885MEN1 1185/4885ALDH1A1 1880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.